Literature DB >> 22016148

Venous thromboembolism in COPD hospitalized patients.

Raquel Barba1, Antonio Zapatero, Javier Marco, Juan E Losa, Susana Plaza, Jose Manuel Casas, Jesús Canora.   

Abstract

Patients with chronic obstructive pulmonary disease (COPD) are at increased risk for venous thromboembolism (VTE). We analyzed a large Spanish database to determine the incidence of VTE in these patients during hospitalization. A retrospective chart review of cohort of consecutive patients admitted with COPD as the primary reason for discharge in Spain between January 1st 2006 and December 31st 2007 was performed. For each patient, demographic data, risk factors for VTE and the diagnosis of VTE during hospitalization was recorded. We analyzed the clinical data of 313,233 adults with acute exacerbations of COPD admitted to the hospital at any public centre in Spain, in 2006 and 2007. We identify 3,562 new diagnosed VTE events among 270,840 COPD patients hospitalized more than two days (incidence 1.32%). Hospitalized-acquired VTE risk factors were male gender (odds ratio [OR] 1.77; CI95% 1.66-1.90), neoplasic disease (OR 2.93 CI95% 2.69-3.16, systemic arterial disease (OR 1.17 CI95% 1.10-1.36), decubitus ulcer (OR 1.19 CI95% 1.01-1.43), diabetes (OR 0.74 IC95% 0.69-0.81), and atrial fibrillation (OR 0.79 CI95% 0.72-0.87). VTE appears as a major threat to patients admitted for acute exacerbation of COPD, and pharmacologic prophylaxis should be considered in all high risk situations.

Entities:  

Mesh:

Year:  2012        PMID: 22016148     DOI: 10.1007/s11239-011-0646-x

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  36 in total

1.  Acquired risk factors for venous thromboembolism in medical patients.

Authors:  Paolo Prandoni
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

Review 2.  Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.

Authors:  Alexander T Cohen; Raza Alikhan; Juan I Arcelus; Jean-François Bergmann; Sylvia Haas; Geno J Merli; Alex C Spyropoulos; Victor F Tapson; Alexander G G Turpie
Journal:  Thromb Haemost       Date:  2005-10       Impact factor: 5.249

3.  Missed opportunities for prevention of venous thromboembolism: an evaluation of the use of thromboprophylaxis guidelines.

Authors:  D M Arnold; S R Kahn; I Shrier
Journal:  Chest       Date:  2001-12       Impact factor: 9.410

4.  Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: methodology for the EXCLAIM study.

Authors:  Russell D Hull; Sebastian M Schellong; Victor F Tapson; Manuel Monreal; Meyer-Michel Samama; Alexander G G Turpie; Peter Wildgoose; Roger D Yusen
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

5.  Venous thromboembolism in acutely ill hospitalized medical patients.

Authors:  Raquel Barba; Antonio Zapatero; Juan E Losa; Javier Marco; Susana Plaza; Jesús Canora; Jose Manuel Casas
Journal:  Thromb Res       Date:  2010-07-24       Impact factor: 3.944

6.  An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study.

Authors:  M M Samama
Journal:  Arch Intern Med       Date:  2000 Dec 11-25

7.  Preventing venous thromboembolism in acute medical patients.

Authors:  A Elis; M H Ellis
Journal:  QJM       Date:  2004-12

8.  The outcome after treatment of venous thromboembolism is different in surgical and acutely ill medical patients. Findings from the RIETE registry.

Authors:  M Monreal; A K Kakkar; J A Caprini; R Barba; F Uresandi; R Valle; C Suarez; R Otero
Journal:  J Thromb Haemost       Date:  2004-11       Impact factor: 5.824

9.  Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism.

Authors:  Victor F Tapson; Hervé Decousus; Mario Pini; Beng H Chong; James B Froehlich; Manuel Monreal; Alex C Spyropoulos; Geno J Merli; Rainer B Zotz; Jean-François Bergmann; Ricardo Pavanello; Alexander G G Turpie; Mashio Nakamura; Franco Piovella; Ajay K Kakkar; Frederick A Spencer; Gordon Fitzgerald; Frederick A Anderson
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

10.  Electronic alerts to prevent venous thromboembolism among hospitalized patients.

Authors:  Nils Kucher; Sophia Koo; Rene Quiroz; Joshua M Cooper; Marilyn D Paterno; Boris Soukonnikov; Samuel Z Goldhaber
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

View more
  1 in total

1.  Effects of simvastatin on tissue factor pathway of blood coagulation in STATCOPE (Simvastatin in the prevention of COPD exacerbations) trial.

Authors:  A Koneti Rao; Fabiola Del Carpio-Cano; Sumalaxmi Janapati; Huaqing Zhao; Helen Voelker; Xiaoning Lu; Gerard Criner
Journal:  J Thromb Haemost       Date:  2021-04-12       Impact factor: 16.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.